Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02429466
Title Study of the Hypomethylating Drug SGI-110 Plus Cisplatin in Relapsed Refractory Germ Cell Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Costantine Albany
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University Hospital Indianapolis Indiana 46202 United States Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field